Evaluation of <i>In Vivo</i> Anti-histaminic and Anti-anaphylactic Activity of <i>Siddha</i> Mono-herbal Formulation <i>Kanduparangi Chooranam</i> (<i>Pygmaeopremna herbacea</i> - Root Powder)
Background: Current treatment options for allergic diseases often have limitations, including adverse effects and low efficacy, while traditional Indian medicine, specifically Siddha formulations, offers potential alternatives. This study evaluates the in-vivo anti-histaminic and anti-anaphylactic activities of Kanduparangi Chooranam (KC), a Siddha mono-herbal formulation prepared from the root powder of Pygmaeopremna herbacea. Materials and methods: The study used Wistar rats for mast cell stabilization and guinea pigs for histamine-induced bronchospasm. KC was given at 100 mg/kg and 200 mg/kg doses. Mast cell stability was measured by intact and disrupted cells, while bronchospasm was assessed by Pre-Convulsive Dyspnea (PCD) time. Data were analyzed using one-way ANOVA and Newman-Keuls tests. Results: Mast cell stabilization: KC significantly increased the percentage of intact mast cells compared to the sensitized control group (p<0.01). The protective effect was observed at both 100 mg/kg and 200 mg/kg doses, with no significant difference between the two. Histamine-induced bronchospasm: KC significantly prolonged the PCD time in guinea pigs compared to the control group (p<0.001), demonstrating its potential bronchodilatory effect. Similar to mast cell stabilization, both KC doses showed comparable efficacy. Discussion: The study suggests that KC stabilizes mast cells by inhibiting degranulation and reducing histamine release. Its ability to prolong PCD time indicates anti-histaminic properties. Similar efficacy at both doses suggests 100 mg/kg may be sufficient for therapeutic use. Conclusion: Kanduparangi Chooranam shows strong anti-histaminic and anti-anaphylactic properties, making it a potential treatment for allergies and asthma. Further studies and clinical trials are needed to confirm its efficacy and explore its role in immune modulation. Major Findings: �In this research, Kanduparangi Chooranam exhibited significant anti-histaminic and anti-anaphylact